ACURA PHARMACEUTICALS, INC (11)
Browse by Contract Category
Contracts
-
Common Stock Warrant issued June 28, 2019 to John Schutte
(Filed With SEC on March 31, 2020)
-
License, Development and Commercialization Agreement is made and entered into as of June 28, 2019 by the Registrant and between Abuse Deterrent Pharmaceuticals, LLC
(Filed With SEC on March 31, 2020)
-
Assignment of Promissory Note, Warrant and Security Agreement issued June 28, 2019 by John Schutte to Abuse Deterrent Pharmaceuticals, LLC
(Filed With SEC on March 31, 2020)
-
Promissory Note Dated June 28, 2019
(Filed With SEC on February 28, 2020)
-
Promissory Note Dated May 1, 2019
(Filed With SEC on February 10, 2020)
-
Promissory Note Dated June 12, 2019
(Filed With SEC on February 10, 2020)
-
Promissory Note Dated March 25, 2019
(Filed With SEC on October 1, 2019)
-
Promissory Note dated October 5, 2018 issued to John Schutte
(Filed With SEC on September 16, 2019)
-
Promissory Note dated November 21, 2018 issued to John Schutte
(Filed With SEC on September 16, 2019)
-
Promissory Note dated December 20, 2018 issued to John Schutte
(Filed With SEC on September 16, 2019)
-
Promissory Note dated January 28, 2019 issued to John Schutte
(Filed With SEC on September 16, 2019)